ethosuximide

Generic: ethosuximide

Labeler: strides pharma science limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ethosuximide
Generic Name ethosuximide
Labeler strides pharma science limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

ethosuximide 250 mg/1

Manufacturer
Strides Pharma Science Limited

Identifiers & Regulatory

Product NDC 64380-878
Product ID 64380-878_7388c216-3de2-4c6d-843c-f2e3b515a611
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211928
Listing Expiration 2026-12-31
Marketing Start 2019-05-15

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64380878
Hyphenated Format 64380-878

Supplemental Identifiers

RxCUI
197682
UPC
0364380878063
UNII
5SEH9X1D1D
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ethosuximide (source: ndc)
Generic Name ethosuximide (source: ndc)
Application Number ANDA211928 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (64380-878-06)
source: ndc

Packages (1)

64380-878-06 100 CAPSULE in 1 BOTTLE (64380-878-06)

Ingredients (1)

ethosuximide (250 mg/1)

Linked Drug Pages (1)

ETHOSUXIMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "7388c216-3de2-4c6d-843c-f2e3b515a611", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0364380878063"], "unii": ["5SEH9X1D1D"], "rxcui": ["197682"], "spl_set_id": ["a4dbc665-4db1-4d0a-9630-5cd200ec4c82"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Strides Pharma Science Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (64380-878-06)", "package_ndc": "64380-878-06", "marketing_start_date": "20190515"}], "brand_name": "ETHOSUXIMIDE", "product_id": "64380-878_7388c216-3de2-4c6d-843c-f2e3b515a611", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "64380-878", "generic_name": "ETHOSUXIMIDE", "labeler_name": "Strides Pharma Science Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ETHOSUXIMIDE", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/1"}], "application_number": "ANDA211928", "marketing_category": "ANDA", "marketing_start_date": "20190515", "listing_expiration_date": "20261231"}